Correlation Between Apogee Therapeutics, and Ardelyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Ardelyx, you can compare the effects of market volatilities on Apogee Therapeutics, and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Ardelyx.

Diversification Opportunities for Apogee Therapeutics, and Ardelyx

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Apogee and Ardelyx is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Ardelyx go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Ardelyx

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the Ardelyx. But the stock apears to be less risky and, when comparing its historical volatility, Apogee Therapeutics, Common is 1.6 times less risky than Ardelyx. The stock trades about -0.24 of its potential returns per unit of risk. The Ardelyx is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  590.00  in Ardelyx on August 29, 2024 and sell it today you would lose (55.00) from holding Ardelyx or give up 9.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Apogee Therapeutics, Common  vs.  Ardelyx

 Performance 
       Timeline  
Apogee Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Ardelyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Apogee Therapeutics, and Ardelyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apogee Therapeutics, and Ardelyx

The main advantage of trading using opposite Apogee Therapeutics, and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.
The idea behind Apogee Therapeutics, Common and Ardelyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements